Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pharma Services company Open Orphan presenting at Hardman's November Forum

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, filmed by London South East on behalf of Hardman.

Open Orphan #ORPH was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.

Hardman Investor Forum: Primary Health Properties, Open Orphan, Surface Transforms, NSF

Cathal Friel, CEO, Open Orphan, #ORPH at the London South East Life Sciences Investor Briefing

What's Hot for #UJO, #ESL, #RENE, #GYM, #TRAF, #SDRY, #ORPH

Related Shares

Login to your account

Don't have an account? Click here to register.